Authors/Disclosures
|
James J. Sejvar, MD, FAAN
(U.S. Centers for Disease Control and Prevention)
|
Dr. Sejvar has nothing to disclose. |
|
David Bargiela, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
Matt T. Bianchi, MD, PhD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
M. B. Westover, MD, PhD
(MGH)
|
Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Brian C. Healy
|
The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Philip De Jager, MD, PhD
(Columbia University Irving Medical Center)
|
Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from Biogen. The institution of Dr. De Jager has received research support from puretech. |
|
|
No disclosure on file |
|
Archana Koganti, MD
(WellStar Health System)
|
No disclosure on file |
|
Maria Vassilaki, MD, PhD
(Mayo Clinic, Department of Quantitative Health Sciences)
|
Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC. |
|
Zongqi Xia, MD, PhD
|
The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Department of Defense. The institution of Dr. Xia has received research support from Genentech/Roche. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |